Revvity

Historical price data

Revvity is a mission-critical enabler in the life sciences and diagnostics sectors, operating as a global technology platform with a vast portfolio of analytical instruments, high-content screening systems, laboratory automation, and informatics software. The company's strategy leverages its deep integration into customer workflows to generate resilient, recurring revenue from consumables, services, and licensing, while benefiting from the long-term growth in R&D and diagnostic spending. Since its strategic separation, Revvity has sharpened its focus on high-growth areas like cell and gene therapy, spatial biology, and multi-omics, positioning itself as a key partner in advancing scientific and clinical research.

An integrated ecosystem of analytical instruments, high-content imaging systems, laboratory automation, specialty diagnostics, enterprise informatics software, and a vast portfolio of reagents and consumables, designed to streamline workflows from basic research through clinical diagnostics.

Revvity competes with giants like Thermo Fisher, Danaher, and Agilent across its portfolio, as well as specialists in imaging and diagnostics. Its competitive edge lies in its integrated workflow approach, high recurring revenue base, and strategic focus on emerging high-growth niches like spatial biology and CGT.